TSCAN THERAPEUTICS, INC. (TCRX) Shareholders’ equity 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) shareholders’ equity at each fiscal year-end, per SEC filings.
$123.1MFY2025 · since FY2020: -$42.5M → $123.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $123.1M | -48.9% |
| FY2024 | $241.0M | +59.7% |
| FY2023 | $150.9M | +51.7% |
| FY2022 | $99.4M | -38.2% |
| FY2021 | $160.8M | +478.6% |
| FY2020 | -$42.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice